Skip to main content

Advertisement

Table 4 The serial change in mean value (SD) of uroflowmetric parameters

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Variable Baseline 1 month 3 months 6 months 12 months
Uroflowmetric parameters     
Vioded Vol.(mL)     
Naftopidil (n=70) 260 (129) 153** (95) 141** (72) 155** (72) 185** (128)
Silodosin (n=71) 209 (111) 151** (89) 128** (81) 144** (76) 172** (100)
Total (n=141) 236 (123) 152** (92) 135** (77) 150** (74) 178** (115)
Qmax (mL/s)
Naftopidil (n=70) 13.2 (6.0) 9.7** (4.4) 8.8** (3.8) 8.9** (3.3) 11.4** (5.4)
Silodosin (n=71) 12.1 (5.2) 9.4** (4.5) 8.7** (4.4) 9.5** (4.6) 11.0** (5.4)
Total (n=141) 12.6 (5.7) 9.6** (4.4) 8.7** (4.1) 9.2** (4.0) 11.2** (5.4)
PVR (mL)
Naftopidil (n=70) 19 (38) 36** (45) 32** (39) 34** (38) 25 (36)
Silodosin (n=71) 23 (27) 38** (36) 52** (71) 37** (34) 35* (45)
Total (n=141) 21 (34) 37** (41) 42** (58) 35** (36) 30* (41)
  1. *p < 0.05, **p < 0.01.